Case Study: Medtech companies achieve patient-centric, paperless trials with Veeva Systems

Medtech’s Path Towards Patient-Centric, Paperless Trials

Veeva Systems outlines how Medtech companies were pushed to reevaluate clinical trials during COVID-19: traditional, paper-based and fragmented study processes created manual rework, higher costs, compliance risk, and a poor patient experience amid rapidly changing global regulations (IVDR/MDR). These challenges made it harder to run agile, reliable studies and to demonstrate product value across the lifecycle.

The recommended solution is a cloud-based, integrated digital platform—using eConsent, ePro, eSource and centralized EDC/TMF with connected stakeholder workflows—to enable patient-centric, paperless trials. This approach reduces administrative burden, improves data quality and collaboration, accelerates study execution and time-to-market, and helps organizations remain audit-ready and compliant.